Symbols / BHC Stock $5.67 +1.61% Bausch Health Companies Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • Canada • NYQ
BHC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Thomas J. Appio
Exch · Country NYQ · Canada
Market Cap 2.12B
Enterprise Value 22.80B
Income 157.00M
Sales 10.27B
FCF (ttm) 1.09B
Book/sh -1.50
Cash/sh 3.53
Employees 20,300
Insider 10d —
IPO Mar 29, 1994
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 13.50
Forward P/E 1.40
PEG 0.01
P/S 0.21
P/B -3.79
P/C —
EV/EBITDA 6.71
EV/Sales 2.22
Quick Ratio 0.88
Current Ratio 1.47
Debt/Eq 5,591.25
LT Debt/Eq —
EPS (ttm) 0.42
EPS next Y 4.04
EPS Growth —
Revenue Growth 9.30%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-29
Earnings (prior) 2026-02-18
ROA 5.18%
ROE 4.36%
ROIC —
Gross Margin 70.65%
Oper. Margin 25.79%
Profit Margin 1.53%
Shs Outstand 373.46M
Shs Float 258.52M
Insider Own 30.41%
Instit Own 64.98%
Short Float 2.10%
Short Ratio 4.73
Short Interest 6.28M
52W High 8.69
vs 52W High -34.75%
52W Low 4.41
vs 52W Low 28.57%
Beta 0.40
Impl. Vol. 6.25%
Rel Volume 1.35
Avg Volume 1.88M
Volume 2.53M
Target (mean) $7.57
Tgt Median $8.00
Tgt Low $6.00
Tgt High $9.00
# Analysts 7
Recom Hold
Prev Close $5.58
Price $5.67
Change 1.61%
About

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$7.57
Mean price target
2. Current target
$5.67
Latest analyst target
3. DCF / Fair value
$52.37
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.67
Low
$6.00
High
$9.00
Mean
$7.57

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-27 main RBC Capital Sector Perform → Sector Perform $9
2026-02-25 main Barclays Equal-Weight → Equal-Weight $7
2026-01-07 main Truist Securities Hold → Hold $8
2025-12-09 init Barclays — → Equal-Weight $8
2025-05-02 main RBC Capital Sector Perform → Sector Perform $10
2025-02-06 down Jefferies Buy → Hold $8
2025-01-30 main RBC Capital Sector Perform → Sector Perform $10
2024-11-01 main RBC Capital Sector Perform → Sector Perform $11
2024-08-02 main RBC Capital Sector Perform → Sector Perform $9
2024-08-02 down Piper Sandler Neutral → Underweight $3
2024-07-25 main Truist Securities Hold → Hold $7
2024-07-10 init Raymond James — → Market Perform $8
2024-04-23 main RBC Capital Sector Perform → Sector Perform $11
2024-04-12 reit RBC Capital Sector Perform → Sector Perform $12
2024-04-05 main RBC Capital Sector Perform → Sector Perform $12
2024-02-23 main RBC Capital Sector Perform → Sector Perform $9
2023-09-20 up Jefferies Hold → Buy $16
2023-06-16 down TD Cowen Outperform → Market Perform —
2023-05-22 main Jefferies Buy → Buy $10
2023-05-05 main RBC Capital — → Sector Perform $8
News
RSS: Latest BHC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-31 WECHSLER AMY B Director — 1,273 $5.40 $6,874
2026-03-31 PAULSON JOHN A. Director — 11,574 $5.40 $62,500
2026-03-31 LEUNG SANDRA Director — 5,946 $5.40 $32,108
2026-03-03 CARSON SEANA LYNNE General Counsel — 11,276 $5.77 $65,131
2026-02-27 CARSON SEANA LYNNE General Counsel — 8,388 $5.95 $49,909
2026-02-25 APPIO THOMAS J Chief Executive Officer — 815,425 $0.00 $0
2026-02-25 CHARHON JEAN-JACQUES Chief Financial Officer — 276,055 $0.00 $0
2026-02-25 LEE STEVEN HYOSIG Officer — 45,868 $0.00 $0
2026-02-25 CARSON SEANA LYNNE General Counsel — 212,350 $0.00 $0
2026-02-25 LENAR AIMEE J Officer — 157,139 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
10,266.00
+6.66%
9,625.00
+9.91%
8,757.00
+7.79%
8,124.00
Operating Revenue
10,156.00
+6.70%
9,518.00
+9.87%
8,663.00
+7.95%
8,025.00
Cost Of Revenue
3,013.00
+8.30%
2,782.00
+8.71%
2,559.00
+8.25%
2,364.00
Reconciled Cost Of Revenue
2,806.00
+8.26%
2,592.00
+9.27%
2,372.00
+8.56%
2,185.00
Gross Profit
7,253.00
+5.99%
6,843.00
+10.41%
6,198.00
+7.60%
5,760.00
Operating Expense
5,068.00
+1.58%
4,989.00
+8.50%
4,598.00
+5.24%
4,369.00
Research And Development
629.00
+2.11%
616.00
+1.99%
604.00
+14.18%
529.00
Selling General And Administration
3,438.00
+4.31%
3,296.00
+12.99%
2,917.00
+11.12%
2,625.00
Total Expenses
8,081.00
+3.99%
7,771.00
+8.58%
7,157.00
+6.30%
6,733.00
Operating Income
2,185.00
+17.85%
1,854.00
+15.88%
1,600.00
+15.03%
1,391.00
Total Operating Income As Reported
1,813.00
+17.27%
1,546.00
+60.54%
963.00
+112.11%
454.00
EBITDA
3,179.00
+12.65%
2,822.00
+28.16%
2,202.00
-19.31%
2,729.00
Normalized EBITDA
3,441.00
+9.10%
3,154.00
+9.17%
2,889.00
+4.52%
2,764.00
Reconciled Depreciation
1,208.00
-4.66%
1,267.00
+0.24%
1,264.00
-9.33%
1,394.00
EBIT
1,971.00
+26.75%
1,555.00
+65.78%
938.00
-29.74%
1,335.00
Total Unusual Items
-262.00
+21.08%
-332.00
+51.67%
-687.00
-1862.86%
-35.00
Total Unusual Items Excluding Goodwill
-262.00
+21.08%
-332.00
+51.67%
-687.00
-1862.86%
-35.00
Special Income Charges
-210.00
+26.32%
-285.00
+55.12%
-635.00
-2251.85%
-27.00
Other Special Charges
13.00
-93.95%
215.00
+498.15%
-54.00
+93.83%
-875.00
Impairment Of Capital Assets
153.00
+427.59%
29.00
-94.70%
547.00
-34.80%
839.00
Restructuring And Mergern Acquisition
50.00
-1.96%
51.00
-64.83%
145.00
+130.16%
63.00
Write Off
—
—
54.00
+260.00%
15.00
Net Income
157.00
+441.30%
-46.00
+92.23%
-592.00
-163.11%
-225.00
Pretax Income
367.00
+119.76%
167.00
+142.82%
-390.00
-202.33%
-129.00
Net Non Operating Interest Income Expense
-1,556.00
-14.83%
-1,355.00
-4.07%
-1,302.00
+10.21%
-1,450.00
Interest Expense Non Operating
1,604.00
+15.56%
1,388.00
+4.52%
1,328.00
-9.29%
1,464.00
Net Interest Income
-1,556.00
-14.83%
-1,355.00
-4.07%
-1,302.00
+10.21%
-1,450.00
Interest Expense
1,604.00
+15.56%
1,388.00
+4.52%
1,328.00
-9.29%
1,464.00
Interest Income Non Operating
48.00
+45.45%
33.00
+26.92%
26.00
+85.71%
14.00
Interest Income
48.00
+45.45%
33.00
+26.92%
26.00
+85.71%
14.00
Other Income Expense
-262.00
+21.08%
-332.00
+51.74%
-688.00
-882.86%
-70.00
Other Non Operating Income Expenses
—
—
-1.00
+97.14%
-35.00
Gain On Sale Of Security
-52.00
-10.64%
-47.00
+9.62%
-52.00
-550.00%
-8.00
Tax Provision
247.00
+3.35%
239.00
+8.14%
221.00
+166.27%
83.00
Tax Rate For Calcs
0.00
+0.00%
0.00
-62.50%
0.00
+52.61%
0.00
Tax Effect Of Unusual Items
-39.30
+21.08%
-49.80
+81.88%
-274.80
-2895.59%
-9.17
Net Income Including Noncontrolling Interests
120.00
+266.67%
-72.00
+88.22%
-611.00
-188.21%
-212.00
Net Income From Continuing Operation Net Minority Interest
157.00
+441.30%
-46.00
+92.23%
-592.00
-163.11%
-225.00
Net Income From Continuing And Discontinued Operation
157.00
+441.30%
-46.00
+92.23%
-592.00
-163.11%
-225.00
Net Income Continuous Operations
120.00
+266.67%
-72.00
+88.22%
-611.00
-188.21%
-212.00
Minority Interests
37.00
+42.31%
26.00
+36.84%
19.00
+246.15%
-13.00
Normalized Income
379.70
+60.75%
236.20
+231.37%
-179.80
+9.73%
-199.17
Net Income Common Stockholders
157.00
+441.30%
-46.00
+92.23%
-592.00
-163.11%
-225.00
Diluted EPS
—
-0.13
+91.98%
-1.62
-161.29%
-0.62
Basic EPS
—
-0.13
+91.98%
-1.62
-161.29%
-0.62
Basic Average Shares
—
353.85
-3.17%
365.43
+0.70%
362.90
Diluted Average Shares
—
353.85
-3.17%
365.43
+0.70%
362.90
Diluted NI Availto Com Stockholders
157.00
+441.30%
-46.00
+92.23%
-592.00
-163.11%
-225.00
Amortization
1,001.00
-7.06%
1,077.00
+0.00%
1,077.00
-11.36%
1,215.00
Amortization Of Intangibles Income Statement
1,001.00
-7.06%
1,077.00
+0.00%
1,077.00
-11.36%
1,215.00
Depreciation Amortization Depletion Income Statement
1,001.00
-7.06%
1,077.00
+0.00%
1,077.00
-11.36%
1,215.00
Depreciation And Amortization In Income Statement
1,001.00
-7.06%
1,077.00
+0.00%
1,077.00
-11.36%
1,215.00
Gain On Sale Of PPE
6.00
-40.00%
10.00
+233.33%
3.00
-40.00%
5.00
Line Item Trend 2023-12-31
Total Assets
27,350.00
Current Assets
5,596.00
Cash Cash Equivalents And Short Term Investments
947.00
Cash And Cash Equivalents
947.00
Receivables
1,998.00
Accounts Receivable
1,998.00
Gross Accounts Receivable
2,032.00
Allowance For Doubtful Accounts Receivable
-34.00
Inventory
1,544.00
Raw Materials
509.00
Work In Process
124.00
Finished Goods
911.00
Prepaid Assets
—
Restricted Cash
15.00
Other Current Assets
1,092.00
Total Non Current Assets
21,754.00
Net PPE
1,707.00
Gross PPE
3,790.00
Accumulated Depreciation
-2,083.00
Properties
0.00
Land And Improvements
74.00
Buildings And Improvements
823.00
Machinery Furniture Equipment
2,053.00
Construction In Progress
401.00
Other Properties
84.00
Leases
355.00
Goodwill And Other Intangible Assets
17,639.00
Goodwill
11,183.00
Other Intangible Assets
6,456.00
Non Current Deferred Assets
2,101.00
Non Current Deferred Taxes Assets
2,101.00
Other Non Current Assets
307.00
Total Liabilities Net Minority Interest
27,432.00
Current Liabilities
4,302.00
Payables And Accrued Expenses
2,451.00
Payables
766.00
Accounts Payable
719.00
Current Accrued Expenses
1,685.00
Pensionand Other Post Retirement Benefit Plans Current
360.00
Total Tax Payable
47.00
Income Tax Payable
47.00
Current Debt And Capital Lease Obligation
450.00
Current Debt
450.00
Other Current Borrowings
—
Current Capital Lease Obligation
—
Other Current Liabilities
1,041.00
Total Non Current Liabilities Net Minority Interest
23,130.00
Long Term Debt And Capital Lease Obligation
21,938.00
Long Term Debt
21,938.00
Long Term Capital Lease Obligation
—
Non Current Deferred Liabilities
163.00
Non Current Deferred Taxes Liabilities
163.00
Other Non Current Liabilities
1,029.00
Stockholders Equity
-1,022.00
Common Stock Equity
-1,022.00
Capital Stock
10,423.00
Common Stock
10,423.00
Share Issued
365.24
Ordinary Shares Number
365.24
Treasury Shares Number
0.00
Additional Paid In Capital
214.00
Retained Earnings
-9,778.00
Gains Losses Not Affecting Retained Earnings
-1,881.00
Minority Interest
940.00
Total Equity Gross Minority Interest
-82.00
Total Capitalization
20,916.00
Working Capital
1,294.00
Invested Capital
21,366.00
Total Debt
22,388.00
Net Debt
21,441.00
Capital Lease Obligations
—
Net Tangible Assets
-18,661.00
Tangible Book Value
-18,661.00
Interest Payable
236.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,400.00
-12.34%
1,597.00
+54.75%
1,032.00
+241.76%
-728.00
Cash Flow From Continuing Operating Activities
1,400.00
-12.34%
1,597.00
+54.75%
1,032.00
+241.76%
-728.00
Net Income From Continuing Operations
120.00
+266.67%
-72.00
+88.22%
-611.00
-188.21%
-212.00
Depreciation Amortization Depletion
1,208.00
-4.66%
1,267.00
+0.24%
1,264.00
-9.33%
1,394.00
Amortization Cash Flow
1,208.00
-4.66%
1,267.00
+0.24%
1,264.00
-9.33%
1,394.00
Depreciation And Amortization
1,208.00
-4.66%
1,267.00
+0.24%
1,264.00
-9.33%
1,394.00
Amortization Of Intangibles
1,208.00
-4.66%
1,267.00
+0.24%
1,264.00
-9.33%
1,394.00
Other Non Cash Items
-40.00
-130.53%
131.00
-13.25%
151.00
+110.27%
-1,471.00
Stock Based Compensation
216.00
+44.00%
150.00
+13.64%
132.00
+4.76%
126.00
Provisionand Write Offof Assets
71.00
+14.52%
62.00
+10.71%
56.00
+9.80%
51.00
Asset Impairment Charge
153.00
+427.59%
29.00
-94.70%
547.00
-34.80%
839.00
Deferred Tax
80.00
+21.21%
66.00
+29.41%
51.00
+128.98%
-176.00
Deferred Income Tax
80.00
+21.21%
66.00
+29.41%
51.00
+128.98%
-176.00
Operating Gains Losses
-189.00
-339.53%
-43.00
-279.17%
24.00
+102.72%
-883.00
Gain Loss On Investment Securities
-10.00
+23.08%
-13.00
+0.00%
-13.00
-116.67%
-6.00
Net Foreign Currency Exchange Gain Loss
-11.00
-466.67%
3.00
-92.68%
41.00
+1266.67%
3.00
Change In Working Capital
-219.00
-3228.57%
7.00
+101.20%
-582.00
-46.97%
-396.00
Change In Receivables
-134.00
+37.96%
-216.00
-10.77%
-195.00
-242.11%
-57.00
Changes In Account Receivables
-134.00
+37.96%
-216.00
-10.77%
-195.00
-242.11%
-57.00
Change In Inventory
-12.00
+95.51%
-267.00
+17.08%
-322.00
-62.63%
-198.00
Change In Prepaid Assets
3.00
-97.74%
133.00
+159.64%
-223.00
-237.88%
-66.00
Change In Payables And Accrued Expense
-76.00
-121.29%
357.00
+125.95%
158.00
+310.67%
-75.00
Change In Payable
-76.00
-121.29%
357.00
+125.95%
158.00
+310.67%
-75.00
Change In Account Payable
-76.00
-121.29%
357.00
+125.95%
158.00
+310.67%
-75.00
Investing Cash Flow
-595.00
-31.06%
-454.00
+78.83%
-2,145.00
-607.92%
-303.00
Cash Flow From Continuing Investing Activities
-595.00
-31.06%
-454.00
+78.83%
-2,145.00
-607.92%
-303.00
Net PPE Purchase And Sale
-397.00
-17.80%
-337.00
-56.74%
-215.00
+1.38%
-218.00
Purchase Of PPE
-397.00
-17.80%
-337.00
-56.74%
-215.00
+1.38%
-218.00
Capital Expenditure
-407.00
-19.71%
-340.00
-25.00%
-272.00
-1.49%
-268.00
Net Investment Purchase And Sale
-3.00
-250.00%
2.00
+300.00%
-1.00
-120.00%
5.00
Purchase Of Investment
-11.00
+8.33%
-12.00
+55.56%
-27.00
-58.82%
-17.00
Sale Of Investment
8.00
-42.86%
14.00
-46.15%
26.00
+18.18%
22.00
Net Business Purchase And Sale
-204.00
-50.00%
-136.00
+92.80%
-1,890.00
-4100.00%
-45.00
Purchase Of Business
-204.00
-50.00%
-136.00
+92.80%
-1,890.00
-4100.00%
-45.00
Net Intangibles Purchase And Sale
-10.00
-233.33%
-3.00
+94.74%
-57.00
-14.00%
-50.00
Purchase Of Intangibles
-10.00
-233.33%
-3.00
+94.74%
-57.00
-14.00%
-50.00
Net Other Investing Changes
7.00
+0.00%
7.00
+40.00%
5.00
+0.00%
5.00
Financing Cash Flow
-742.00
+14.52%
-868.00
-158.85%
1,475.00
+411.18%
-474.00
Cash Flow From Continuing Financing Activities
-742.00
+14.52%
-868.00
-158.85%
1,475.00
+411.18%
-474.00
Net Issuance Payments Of Debt
-637.00
+20.28%
-799.00
-150.54%
1,581.00
+256.53%
-1,010.00
Issuance Of Debt
10,554.00
+1496.67%
661.00
-79.91%
3,291.00
-51.86%
6,836.00
Repayment Of Debt
-11,191.00
-666.51%
-1,460.00
+14.62%
-1,710.00
+78.21%
-7,846.00
Long Term Debt Issuance
10,554.00
+1496.67%
661.00
-79.91%
3,291.00
-51.86%
6,836.00
Long Term Debt Payments
-11,191.00
-666.51%
-1,460.00
+14.62%
-1,710.00
+78.21%
-7,846.00
Net Long Term Debt Issuance
-637.00
+20.28%
-799.00
-150.54%
1,581.00
+256.53%
-1,010.00
Short Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
—
—
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
—
0.00
0.00
-100.00%
675.00
Net Other Financing Charges
-105.00
-52.17%
-69.00
+34.91%
-106.00
+23.74%
-139.00
Changes In Cash
63.00
-77.09%
275.00
-24.03%
362.00
+124.05%
-1,505.00
Effect Of Exchange Rate Changes
61.00
+269.44%
-36.00
-500.00%
9.00
+139.13%
-23.00
Beginning Cash Position
1,201.00
+24.84%
962.00
+62.77%
591.00
-72.11%
2,119.00
End Cash Position
1,325.00
+10.32%
1,201.00
+24.84%
962.00
+62.77%
591.00
Free Cash Flow
993.00
-21.00%
1,257.00
+65.39%
760.00
+176.31%
-996.00
Interest Paid Supplemental Data
1,810.00
+8.12%
1,674.00
+9.20%
1,533.00
-0.45%
1,540.00
Income Tax Paid Supplemental Data
163.00
+167.21%
61.00
-74.26%
237.00
-10.90%
266.00
Common Stock Issuance
—
0.00
0.00
-100.00%
675.00
Interest Received CFI
12.00
-7.69%
13.00
+0.00%
13.00
0.00
Issuance Of Capital Stock
—
0.00
0.00
-100.00%
675.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category